Negrin Lukas Leopold, Vécsei Vilmos
Department of Trauma Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria,
J Orthop Sci. 2013 Nov;18(6):940-8. doi: 10.1007/s00776-013-0449-3. Epub 2013 Aug 10.
To test the hypothesis that autologous chondrocyte implantation (ACI) has a better treatment effect than microfracture (MF), and increasing superiority over the years, when performed under similar patient-specific and defect-specific conditions.
We scanned four electronic databases for controlled clinical trials or controlled prospective observational studies. We conducted random-effects meta-analyses of equivalent data using standardized mean differences as the outcome measure of choice at 1, 2, and 5-year follow-up. We assessed heterogeneity with the I (2) index and publication bias with funnel plots and Kendall's tests.
Our literature search revealed six study populations (nine papers) which satisfied our eligibility criteria. Overall, 399 patients aged between 16 and 60 years with 1-10 cm(2) chondral defects were available. The MF and the ACI study groups were well matched regarding patient baseline characteristics. For all papers, microfracture was performed according to Steadman, whereas three generations of ACI were applied. When all were combined, non-significant superiority of ACI over MF was revealed; surprisingly, this superiority decreased over the years. However, our meta-analyses combining solely second and third-generation ACI revealed significant standardized differences, becoming smaller over the years, but always representing a large effect. Nevertheless, our approximate estimate of the difference between the treatment effects provoked by second and third-generation ACI and by MF is not indicative of clinically relevant superiority of ACI over MF at 5-year follow-up.
Both series of meta-analyses (combining either all ACI modifications or solely the second and third generations of ACI) suggest that the treatment effects resulting from ACI and MF converge over the years.
检验以下假设:在相似的患者个体和缺损特定条件下进行自体软骨细胞移植(ACI)比微骨折术(MF)具有更好的治疗效果,且多年来优势不断增加。
我们检索了四个电子数据库,查找对照临床试验或对照前瞻性观察研究。我们使用标准化均数差作为选择的结局指标,在1年、2年和5年随访时对等效数据进行随机效应荟萃分析。我们用I²指数评估异质性,用漏斗图和肯德尔检验评估发表偏倚。
我们的文献检索发现了六个符合纳入标准的研究群体(九篇论文)。总体而言,共有399例年龄在16至60岁之间、软骨缺损面积为1至10平方厘米的患者。MF和ACI研究组在患者基线特征方面匹配良好。对于所有论文,微骨折术均按照斯特德曼方法进行,而ACI应用了三代技术。当全部合并时,ACI相对于MF的优势无统计学意义;令人惊讶的是,这种优势多年来有所下降。然而,我们仅将第二代和第三代ACI合并的荟萃分析显示存在显著的标准化差异,多年来差异变小,但始终代表较大效应。尽管如此,我们对第二代和第三代ACI与MF所引发的治疗效果差异的近似估计并不表明在5年随访时ACI相对于MF具有临床相关优势。
这两组荟萃分析(合并所有ACI改良技术或仅合并第二代和第三代ACI)均表明,多年来ACI和MF的治疗效果趋于一致。